Related Experiment Video
Updated: Aug 20, 2026

Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 30, 2010
[Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline]
Noboru Higuchi1, Hiroki Maruyama
1Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences.
Abstract:
According to the Kidney disease outcomes quality initiative (K/DOQI) guideline, in order to decrease risk of beta2-microglobulin amyloidosis, noncuprophane (EVIDENCE), high-flux dialyzers (OPINION) should be used. No currently available therapy, except kidney transplantation, can stop disease progression of beta2-microglobulin amyloidosis or provide symptomatic relief (EVIDENCE). Screening for beta2-microglobulin amyloidosis, including measurement of serum levels of beta2-microglobulin, is not recommended (OPINION).
Related Concept Videos
Alzheimer's Disease: Treatment
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
